For many, the high cost of the injection means stopping is a matter of 'when,' not 'if.' Endocrinologists reveal the crucial ...

A once-weekly injection of Wegovy® has become available in Singapore, marking the latest step in managing obesity as a ...

A new study finds four factors that may make it more likely for some people to experience successful weight loss from using ...

Wegovy is a prescription injection used for weight loss and reduction of cardiovascular risks. Learn about its dose escalation, form, strengths, and more.

Novo Nordisk submits a higher 7.2 mg dose of Wegovy for EMA approval, backed by trials showing 21% weight loss in obesity and ...

Business Insider spoke to Eli Lilly's new president of cardiometabolic health, who shared the company's aggressive incretin ...

Experts are warning anyone experiencing GLP-1 drug side effects to report them after launching an investigation into their safety.

Pharmacy benefit manager CVS Caremark drops Zepbound coverage, estimating 10-15% savings while Eli Lilly offers self-pay ...

Novo Nordisk NVO announced that it has submitted a regulatory application to the European Medicines Agency (EMA) seeking ...

Find out how Wegovy works for weight loss and the prevention of certain cardiovascular problems.

Novo Nordisk is a global diabetes and weight loss leader with strong long-term growth prospects. Read why NVO stock is a ...

A New Zealand bariatric surgeon cautions that Wegovy, a new weight-loss drug, isn't a magic bullet for obesity. While it can trigger initial weight loss, long-term success hinges on lifestyle changes ...